相关实验视频
Updated: Sep 9, 2025

06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
6.8K
瘤性疹简单病毒治疗:最新进展,核心挑战和未来前景
Yiyang Zheng1, Yusheng Pei1, Chunyan Dong1
1State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing 102629, China.
Vaccines
|August 28, 2025
概括
瘤性简单性疹病毒 (oHSV) 治疗在癌症治疗中具有前景,其中包括基因修饰和组合疗法. 未来的研究重点是精密工程和新型输送系统,以提高耐火性癌症的疗效.
科学领域:
- 癌症学
- 病毒学
- 免疫疗法
背景情况:
- 瘤性病毒 (OV) 治疗,特别是瘤性简单疹病毒 (oHSV),是一种新兴的癌症治疗策略.
- 临床里程碑包括Talimogene laherparepvec (T-VEC) 和Teserpaturev/ G47Δ的FDA批准.
研究的目的:
- 综合过去十年oHSV治疗的临床前和临床进展.
- 分析目标选择,基因改造,管理和交付方面的挑战.
- 审查oHSV的新型传输工具和基因编辑策略.
主要方法:
- 对oHSV治疗的临床前和临床研究的文献综述.
- 对基因改造技术和传递系统的分析.
- 评估与免疫调节转基因和免疫检查点抑制剂的组合策略.
主要成果:
- 使用免疫调节转基因 (细胞因子,抗体) 加强oHSV的治疗效果.
- 将oHSV与免疫检查点抑制剂结合在一起是改善结果的关键策略.
- 像纳米颗粒和介质干细胞 (MSC) 这样的新型输送工具显示出潜力.
结论:
- 对于耐火性癌症,oHSV治疗是一个有前途的策略.
- 使用CRISPR/Cas9的精密工程和以生物标志物为指导的个性化医学是未来的研究方向.
- 主要目标是开发更安全,更有效的基于oHSV的治疗方法.
相关概念视频
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Subviral Agents
111
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

